1010 related articles for article (PubMed ID: 30339386)
21. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
[TBL] [Abstract][Full Text] [Related]
22. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
[TBL] [Abstract][Full Text] [Related]
23. Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes.
Dömötör O; de Almeida RF; Côrte-Real L; Matos CP; Marques F; Matos A; Real C; Kiss T; Enyedy ÉA; Helena Garcia M; Tomaz AI
J Inorg Biochem; 2017 Mar; 168():27-37. PubMed ID: 28006663
[TBL] [Abstract][Full Text] [Related]
24. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
[TBL] [Abstract][Full Text] [Related]
25. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
26. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
27. Comparative solution equilibrium studies of antitumor ruthenium(η
Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
29. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
[TBL] [Abstract][Full Text] [Related]
30. Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
Clavel CM; Păunescu E; Nowak-Sliwinska P; Griffioen AW; Scopelliti R; Dyson PJ
J Med Chem; 2015 Apr; 58(8):3356-65. PubMed ID: 25812075
[TBL] [Abstract][Full Text] [Related]
31. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
[TBL] [Abstract][Full Text] [Related]
32. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
[TBL] [Abstract][Full Text] [Related]
33. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
[TBL] [Abstract][Full Text] [Related]
35. Half-sandwich Ru(η
Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
[TBL] [Abstract][Full Text] [Related]
36. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
37. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD
J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374
[TBL] [Abstract][Full Text] [Related]
38. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation.
Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA
Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives.
Obradović D; Nikolić S; Milenković I; Milenković M; Jovanović P; Savić V; Roller A; Đorđić Crnogorac M; Stanojković T; Grgurić-Šipka S
J Inorg Biochem; 2020 Sep; 210():111164. PubMed ID: 32634653
[TBL] [Abstract][Full Text] [Related]
40. Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells.
Kumar P; Mondal I; Kulshreshtha R; Patra AK
Dalton Trans; 2020 Oct; 49(38):13294-13310. PubMed ID: 32936191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
